<DOC>
	<DOCNO>NCT00843518</DOCNO>
	<brief_summary>The purpose study determine whether drug help symptoms aggression agitation patient Alzheimer 's disease .</brief_summary>
	<brief_title>Treatment Aggression Agitation Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>The primary purpose study help answer follow research question : - Whether drug help symptoms aggression agitation subject Alzheimer 's Disease . - The safety drug side effect might associate . - How drug compare placebo . During 12-week period study , patient equal chance receive 1 2 treatment group active drug placebo .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>Communitydwelling patient diagnosis probable Alzheimer 's disease ( AD ) , base disease diagnostic criterion , Mini Mental State Examination ( MMSE ) score 6 26 inclusive , NPI10 total score great equal 10 , significant neuropsychiatric symptom . Are men woman least 60 year old . Weigh great equal 45 kg . Have clinically significant persistent verbal physical agitation and/or verbal physical aggression behavior disruptive daily function potentially harmful . Understand English . Have reliable actively involved caregiver must able communicate English willing comply protocol requirement . Have delirium . Meet criterion vascular dementia . Have MRI CT scan file since onset symptom AD perform within past 24 month inconsistent diagnosis AD . Have current , require use expect use psychoactive drug medication allow trial . Have currently active significant medical problem allow trial brain disorder . Have receive acetylcholinesterase inhibitor ( AChEIs ) memantine le 4 month , less 2 month stable therapy treatment Visit 2 .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Agitation Aggression</keyword>
</DOC>